Literature DB >> 21166593

The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?

Amy Andrew1, Klaus Strebel.   

Abstract

Viruses face a variety of obstacles when infecting a new host. The past few years have brought exciting new insights into the function of restriction factors, which form part of the host's innate immune system. One of the most recently identified restriction factors is bone marrow stromal antigen 2 (BST-2)/tetherin. BST-2 is an interferon-inducible gene whose expression dramatically reduces the release of viruses from infected cells. This effect of BST-2 is not specific to human immunodeficiency virus but affects a broad range of enveloped viruses. Since the identification of BST-2 as a restriction factor in 2008, much progress has been made in understanding the molecular properties and functional characteristics of this host factor. The goal of this review was to provide an update on our current understanding of the role of BST-2 in regulating virus release and to discuss its role in controlling virus spread during productive infection with special emphasis on human immunodeficiency virus-1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21166593      PMCID: PMC3021358          DOI: 10.1089/jir.2010.0108

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  82 in total

1.  Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu.

Authors:  Christine Goffinet; Stefanie Homann; Ina Ambiel; Nadine Tibroni; Daniel Rupp; Oliver T Keppler; Oliver T Fackler
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

2.  Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain.

Authors:  Andreas Hinz; Nolwenn Miguet; Ganesh Natrajan; Yoshiko Usami; Hikaru Yamanaka; Patricia Renesto; Bettina Hartlieb; Andrew A McCarthy; Jean-Pierre Simorre; Heinrich Göttlinger; Winfried Weissenhorn
Journal:  Cell Host Microbe       Date:  2010-04-22       Impact factor: 21.023

3.  CD317/tetherin is enriched in the HIV-1 envelope and downregulated from the plasma membrane upon virus infection.

Authors:  Anja Habermann; Jacomine Krijnse-Locker; Heike Oberwinkler; Manon Eckhardt; Stefanie Homann; Amy Andrew; Klaus Strebel; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

4.  Interplay between ovine bone marrow stromal cell antigen 2/tetherin and endogenous retroviruses.

Authors:  Frederick Arnaud; Sarah G Black; Lita Murphy; David J Griffiths; Stuart J Neil; Thomas E Spencer; Massimo Palmarini
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

5.  Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors.

Authors:  Harriet C T Groom; Melvyn W Yap; Rui Pedro Galão; Stuart J D Neil; Kate N Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

6.  Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment.

Authors:  Mathieu Dubé; Bibhuti Bhusan Roy; Pierre Guiot-Guillain; Julie Binette; Johanne Mercier; Antoine Chiasson; Eric A Cohen
Journal:  PLoS Pathog       Date:  2010-04-08       Impact factor: 6.823

Review 7.  Human cellular restriction factors that target HIV-1 replication.

Authors:  Klaus Strebel; Jeremy Luban; Kuan-Teh Jeang
Journal:  BMC Med       Date:  2009-09-16       Impact factor: 8.775

8.  Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein.

Authors:  Anna Le Tortorec; Stuart J D Neil
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

9.  The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu.

Authors:  Amy J Andrew; Eri Miyagi; Sandra Kao; Klaus Strebel
Journal:  Retrovirology       Date:  2009-09-08       Impact factor: 4.602

10.  The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin.

Authors:  Claire Pardieu; Raphaël Vigan; Sam J Wilson; Alessandra Calvi; Trinity Zang; Paul Bieniasz; Paul Kellam; Greg J Towers; Stuart J D Neil
Journal:  PLoS Pathog       Date:  2010-04-15       Impact factor: 6.823

View more
  21 in total

1.  C-terminal hydrophobic region in human bone marrow stromal cell antigen 2 (BST-2)/tetherin protein functions as second transmembrane motif.

Authors:  Amy J Andrew; Sandra Kao; Klaus Strebel
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  BST-2/tetherin: viral tether, viral sensor or both?

Authors:  Jean K Gustin; Janet L Douglas
Journal:  Future Virol       Date:  2013-11       Impact factor: 1.831

Review 3.  HIV-1 Vpu - an ion channel in search of a job.

Authors:  Klaus Strebel
Journal:  Biochim Biophys Acta       Date:  2013-07-03

Review 4.  New insights into HIV assembly and trafficking.

Authors:  Muthukumar Balasubramaniam; Eric O Freed
Journal:  Physiology (Bethesda)       Date:  2011-08

5.  Misdirection of membrane trafficking by HIV-1 Vpu and Nef: Keys to viral virulence and persistence.

Authors:  Andrey Tokarev; John Guatelli
Journal:  Cell Logist       Date:  2011-05

6.  Positioning of cysteine residues within the N-terminal portion of the BST-2/tetherin ectodomain is important for functional dimerization of BST-2.

Authors:  Sarah Welbourn; Sandra Kao; Kelly E Du Pont; Amy J Andrew; Christopher E Berndsen; Klaus Strebel
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

Review 7.  Tetherin/BST-2: Restriction Factor or Immunomodulator?

Authors:  Sam X Li; Bradley S Barrett; Kejun Guo; Mario L Santiago
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

8.  The size and conservation of a coiled-coil structure in the ectodomain of human BST-2/tetherin is dispensable for inhibition of HIV-1 virion release.

Authors:  Amy J Andrew; Christopher E Berndsen; Sandra Kao; Klaus Strebel
Journal:  J Biol Chem       Date:  2012-11-14       Impact factor: 5.157

9.  Filamin A Is Involved in HIV-1 Vpu-mediated Evasion of Host Restriction by Modulating Tetherin Expression.

Authors:  Dominique Dotson; Elvin A Woodruff; Fernando Villalta; Xinhong Dong
Journal:  J Biol Chem       Date:  2016-01-07       Impact factor: 5.157

10.  Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 Isolates.

Authors:  Chia-Yen Chen; Masashi Shingai; Sarah Welbourn; Malcolm A Martin; Pedro Borrego; Nuno Taveira; Klaus Strebel
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.